Category Archives: Neuroscience

Study Finds That Community Treatment Orders Do Not Reduce Hospital Readmission Rates or Stays – Global Health News Wire

This research finds that CTOs are associated with an increased risk of readmission as well as increased time spent in psychiatric hospitals

In the first large, observational study with a control group in England and Wales, research funded by the NIHR Maudsley Biomedical Research Centre has found that Community Treatment Orders (CTOs) are associated with an increased risk of readmission as well as increased time spent in psychiatric hospitals, contrary to results from previous uncontrolled studies. Researchers suggest that these findings should be considered in future reforms to the UK Mental Health Act.

CTOs were introduced in England and Wales under the 2007 amendment to the Mental Health Act (1983). They are a legal order for compulsory monitoring and treatment of people discharged from psychiatric hospitals with serious mental disorders within a community care setting. They also allow quicker readmission to hospital, if necessary, following suspected relapse. Their use has exceeded initial expectation and 5,000 are now used in England each year on average.

Researchers compared 830 patients who were discharged on a CTO with 3,659 patients discharged to voluntary community mental healthcare. Results showed that in the two years following discharge from psychiatric hospital, patients on CTOs spent, on average, 17.3 additional days in hospital and had a 60% greater rate of readmission compared to patients receiving voluntary care. The study also found that the average CTO lasted three years, more than four times longer than initial government projections of nine months.

These findings are contrary to previous uncontrolled observational studies carried out in the UK and Wales, some of which reported a reduction in readmission rates in patients on CTOs. However, the addition of a control group of patients discharged without a CTO in this study allowed researchers to compare outcomes more robustly than in previous studies.

These results could be due to the tendency for patients with CTOs to have historic relapses and severe symptoms, or due to the ease of readmission through the CTO pathway.

Lead author Dr. Rashmi Patel, MRC UKRI Health Data Research UK Fellow at the Institute of Psychiatry, Psychology & Neuroscience at Kings College London, said: Community Treatment Orders were designed to prevent relapse and readmission to hospital for people with serious mental illnesses. In fact, our study suggests that they have the opposite effect, with people on CTOs being more likely to be readmitted and spending longer in hospital. In light of these findings, we need to think carefully about what role (if any) CTOs should play in providing care to people with serious mental illnesses.

Co-author Dr. Alexis Cullen, Research Fellow at the Institute of Psychiatry, Psychology & Neuroscience at Kings College London added While we cannot establish a causal effect of CTOs on readmission rates, our findings concur with smaller randomised controlled trials from the UK in showing that readmission rates are not reduced. Importantly, our inclusion of patients treated in forensic psychiatric settings (who have been excluded from previous studies) means that our sample is more reflective of the patients who typically receive these treatments.

Researchers used the Clinical Record Interactive Search (CRIS) system which has access to over 400,000 anonymised electronic health records from the South London and Maudsley NHS Foundation Trust. Records available from patients who were discharged between 2008 and 2014 under the Mental Health Act were analysed.

View original post here:
Study Finds That Community Treatment Orders Do Not Reduce Hospital Readmission Rates or Stays - Global Health News Wire

Hormone Linked to Pain Difference Between Men and Women – Technology Networks

Imagine taking a pill to control your pain and, instead, the medication actually increases the pain you feel. That may be the situation for patients who take opioids, but even more so for women, according to groundbreaking research by investigators at the University of Arizona College of Medicine Tucson in the Department of Pharmacology.The researchers identified a mechanism that explains why women may be more vulnerable than men to develop pain in general, as well as to develop pain from opioids specifically.

The cause is a neurohormone, prolactin, known largely for promoting lactation in expectant mothers in their final months of pregnancy and after childbirth.

Frank Porreca, PhD, associate department head, a professor of Pharmacology, anesthesiology, cancer biology and neuroscience at the college, and senior author on the study, notes it always has been understood that women experience some types of pain that occur without injury (known as functional pain syndromes) more than men. The reasons for this never were clearly understood. A possible explanation the researchers explored was the differences in the cells and nerves that send pain signals to the brain in women and men.

Now, their paper pinpoints these sex differences to the prolactin receptor, which regulates sensitization of nociceptors neurofibers that conduct pain impulses and pain from opioids (opioid-induced hyperalgesia) selectively in female laboratory mice. The second point is important, Dr. Porreca explains, because they found opioids also produce a release of prolactin in women that in turn increases pain instead of lessening it.

The findings suggest new pain-management therapies targeting the prolactin system would greatly benefit women suffering from functional pain syndromes.

Of all these female-prevalent pain disorders, migraines are among the most common, with about 35 million migraine patients in the United States, and three out of four of those are women. In addition, in fibromyalgia patients, as many as nine out of 10 are women; for irritable bowel syndrome, three out of four are women. When you add up all those women with pain if you can normalize that this would provide a huge and important impact on medical care, Dr. Porreca says.

In that context, he adds, being female can be considered a risk factor for increased pain. Now, they know one important reason why. Nobody's ever understood this until now, Dr. Porreca says.

He points out many of these pain spells are intermittent and associated with triggering events. For instance, he and his colleagues found stress releases prolactin and unexpectedly promotes pain selectively in females.

These triggering events can be wide-ranging. They can include things like alcohol, fatigue and sleep disruption. But stress is the most common trigger self-identified by patients. That's where we started our studies how does stress contribute to female-specific pain or female-selective pain?

Primary authors on the paper include: Yanxia Chen, a graduate student in Dr. Porrecas lab; Aubin Moutal, PhD, a research assistant professor in the Department of Pharmacology, working in the lab of Rajesh Khanna, PhD, a UArizona professor of anesthesiology, pharmacology and neuroscience, who also is a co-author on the paper; and Edita Navratilova, PhD, an assistant professor of pharmacology.

Dr. Navratilova says dopamine D-2 receptor agonist drugs that limit prolactin release, such as cabergoline, commonly are used for other diseases, and are not addictive. These drugs, possibly in conjunction with other classes of medications, may help treat those pain conditions in women more effectively without the addictive properties of opioids.

If we could just reduce the proportion of women who have migraines to the same amount as in men, that would be quite revolutionary, Dr. Navratilova says.

In addition, since publication of their findings, Dr. Porreca has been contacted by companies interested in investigating whether an antibody previously associated with breast cancer treatment might be able to be engineered as a therapy to guard against pain in women.ReferenceChen et al. (2020) The prolactin receptor long isoform regulates nociceptor sensitization and opioid-induced hyperalgesia selectively in females. Science Translational Medicine. DOI: https://doi.org/10.1126/scitranslmed.aay7550

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

The rest is here:
Hormone Linked to Pain Difference Between Men and Women - Technology Networks

Neuroscience Antibodies & Assays Market 2020 | Applications, Challenges, Growth, Shares, Trends and Forecast To 2026 – Packaging News 24

The report on the Neuroscience Antibodies & Assays Market is a compilation of intelligent, broad research studies that will help players and stakeholders to make informed business decisions in future. It offers specific and reliable recommendations for players to better tackle challenges in the Neuroscience Antibodies & Assays market. Furthermore, it comes out as a powerful resource providing up to date and verified information and data on various aspects of the Neuroscience Antibodies & Assays market. Readers will be able to gain deeper understanding of the competitive landscape and its future scenarios, crucial dynamics, and leading segments of the Neuroscience Antibodies & Assays market. Buyers of the report will have access to accurate PESTLE, SWOT, and other types of analysis on the Neuroscience Antibodies & Assays market.

Neuroscience Antibodies & Assays Market was valued at USD 2.42 Billion in 2018 and is projected to reach USD 5.14 Billion by 2026, growing at a CAGR of 9.7% from 2019 to 2026.

Get | Download Sample Copy @ https://www.verifiedmarketresearch.com/download-sample/?rid=28342&utm_source=PN24&utm_medium=003

Popular Players

Competition is a major subject in any market research analysis. With the help of the competitive analysis provided in the report, players can easily study key strategies adopted by leading players of the Neuroscience Antibodies & Assays market. They will also be able to plan counterstrategies to gain a competitive advantage in the Neuroscience Antibodies & Assays market. Major as well as emerging players of the Neuroscience Antibodies & Assays market are closely studied taking into consideration their market share, production, revenue, sales growth, gross margin, product portfolio, and other significant factors. This will help players to become familiar with the moves of their toughest competitors in the Neuroscience Antibodies & Assays market.

The report is just the right tool that players need to strengthen their position in the Neuroscience Antibodies & Assays market. It is also the perfect resource that will help players to sustain their lead or achieve a competitive position in the Neuroscience Antibodies & Assays market.

Key Players Mentioned in the Neuroscience Antibodies & Assays Market Research Report:

Top Segments

The segmental analysis section of the report includes a thorough research study on key type and application segments of the Neuroscience Antibodies & Assays market. All of the segments considered for the study are analyzed in quite some detail on the basis of market share, growth rate, recent developments, technology, and other critical factors. The segmental analysis provided in the report will help players to identify high-growth segments of the Neuroscience Antibodies & Assays market and clearly understand their growth journey.

Ask for Discount @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=28342&utm_source=PN24&utm_medium=003

Leading Regions

The authors of the report have analyzed both developing and developed regions considered for the research and analysis of the Neuroscience Antibodies & Assays market. The regional analysis section of the report provides an extensive research study on different regional and country-wise Neuroscience Antibodies & Assays markets to help players plan effective expansion strategies. Moreover, it offers highly accurate estimations on the CAGR, market share, and market size of key regions and countries. Players can use this study to explore untapped Neuroscience Antibodies & Assays markets to extend their reach and create sales opportunities.

Get Customized Report in your Inbox within 24 hours @ https://www.verifiedmarketresearch.com/product/Neuroscience-Antibodies-&-Assays-Market/?utm_source=PN24&utm_medium=003

Highlights of the Report

About Us:

Verified market research partners with clients to provide insight into strategic and growth analytics; data that help achieve business goals and targets. Our core values include trust, integrity, and authenticity for our clients.

Analysts with high expertise in data gathering and governance utilize industry techniques to collate and examine data at all stages. Our analysts are trained to combine modern data collection techniques, superior research methodology, subject expertise and years of collective experience to produce informative and accurate research reports.

Contact Us:

Mr. Edwyne FernandesCall: +1 (650) 781 4080Email: [emailprotected]

TAGS: Neuroscience Antibodies & Assays Market Size, Neuroscience Antibodies & Assays Market Growth, Neuroscience Antibodies & Assays Market Forecast, Neuroscience Antibodies & Assays Market Analysis, Neuroscience Antibodies & Assays Market Trends, Neuroscience Antibodies & Assays Market

See the rest here:
Neuroscience Antibodies & Assays Market 2020 | Applications, Challenges, Growth, Shares, Trends and Forecast To 2026 - Packaging News 24

The Mind Is the Opposite of a Computer – Walter Bradley Center for Natural and Artificial Intelligence

Matthew Cobb (right) is a British neuroscientist who blogs on occasion on Darwinian evolutionary biologist Jerry Coynes Why Evolution is True blog. Despite this inauspicious hobby, he has written a good essay in The Guardian, Why your brain is not a computer on the shortcomings of the computational model of the brain:

And yet there is a growing conviction among some neuroscientists that our future path [to understanding how the brain works] is not clear. It is hard to see where we should be going, apart from simply collecting more data or counting on the latest exciting experimental approach. As the German neuroscientist Olaf Sporns has put it: Neuroscience still largely lacks organising principles or a theoretical framework for converting brain data into fundamental knowledge and understanding. Despite the vast number of facts being accumulated, our understanding of the brain appears to be approaching an impasse.

So true. Philosopher Roger Scruton (19442020) said it best (I paraphrase): neuroscience is a vast trove of answers with no memory of the questions. Cobb continues:

For more than half a century, [neuroscience has been] framed by thinking that brain processes involve something like those carried out in a computer. But that does not mean this metaphor will continue to be useful in the future. At the very beginning of the digital age, in 1951, the pioneer neuroscientist Karl Lashley argued against the use of any machine-based metaphor.

Descartes was impressed by the hydraulic figures in the royal gardens, and developed a hydraulic theory of the action of the brain, Lashley wrote. We have since had telephone theories, electrical field theories and now theories based on computing machines and automatic rudders. I suggest we are more likely to find out about how the brain works by studying the brain itself, and the phenomena of behaviour, than by indulging in far-fetched physical analogies.

Cobb is rightmodels of the brain tend to track with the latest technology. To some ancient philosophers, the brain worked by making heat, like a fire. To Descartes the brain was hydraulic. To 19th century materialists, writing amid the Industrial Revolution, the brain was a machine. To 21st century materialists, the brain is a computer. Our tools at hand become our metaphors.

But metaphors are not metaphysics. Often, metaphors lead us astray. In some sense, the atom is like a little solar system, with electrons orbiting the nucleus like planets orbiting the sun. But quantum mechanics revealed dynamics utterly unlike the solar system model of the atom pictured by early twentieth century pioneers in the field like Ernest Rutherford and Niels Bohr.

Similarly, the eye is in some ways, like a camera. But if you understood only cameras and did not understand ocular physiology and neurophysiology, you will understand pitifully little about the eye.

So, what is the brain? How does it work? As Scruton noted, we need to make the questions more clear. Several questions are embedded in the issues Cobb raises.

One at a time:

1.Is the brain a kind of computer? First and foremost, the brain is an organ and it does organ thingsit metabolizes, secretes, generates action potentials and neurotransmitters, etc. But is it also a computer?

The answer depends on how you define computation. If computation is the mapping of an input to an output according to a set of rules (which is the usual broad definition of computation), then some aspects of brain function are computation. There are inputs (sensory inputs, electrical and chemical stimuli, etc.) and these inputs are in some situations mapped to outputs (transmission of action potentials, secretion of neurotransmitters, reflexes, etc.) according to rules (neurophysiological principles). Perhaps this application of computation to brain function is trivial, perhaps not, but in this sense some aspects of brain function are computational.

As well see below, however, not all aspects of brain function are computational, so the brain cannot be described entirely as a computer. And I would point out to Cobb (who is a materialist and atheist) that computation intrinsically entails teleology which (by Aquinas Fifth Way) demonstrates the existence of God. Atheists should be careful about computational models in biology, because computation is the product of intelligent design. Computers and software dont just happen by themselves.

2.What is the relation between the brain and the mind? Cobb is a materialist so I presume he discounts dualism. However, abstract thought (as classical philosophers pointed out) is inherently an immaterial ability and thus it cannot arise from the brain or from any material organ. Concrete thought can be material in origin but that view presupposes a metaphysical understanding of matter that is considerably more sophisticated than Cobbs materialism. Hylemorphism is the best metaphysical perspective from which to understand the material and immaterial powers of the mind.

3. Is the mind a kind of computation? No. In fact, the mind is the antithesis of computation. The reason is obvious when you think about it. Mental activity always has meaningevery thought is about something. Computation always lacks meaning in itself. A word processing program doesnt care about the opinion that youre expressing when you use it. A digital camera doesnt care what youre taking a picture of. In fact, the great utility of computation is that it doesnt have its own meaning so you can use it as a substrate to express any meaning you choose. Because the mind always has meaning and computation never has meaning, the mind is not computation. In fact, the mind is the opposite of computation.

Succinctly, the brain is an organ and some of its functions can be described as computation. The mind is obviously related to the brain but the relationship is complex and is best understood from the perspective of hylemorphic metaphysics. Concrete thought arises from brain function but abstract thought is inherently immaterial. Although abstract thought is influenced by brain function, it does not arise from it. The mind itself (as distinct from the brain) is no form of computation, and in fact the mind is the antithesis of computation.

Cobb is in the right track in critiquing the computational model of the brain and the mind. His materialism prevents him from following his genuine insights to their logical conclusion: Human beings have souls with material and immaterial powers, and some of the material powers are caused by the brain.

Cobb is shortly publishing a book, The Idea of the Brain, of which his essay in The Guardian is an edited excerpt. It looks like a worthwhile read. He understands the limitations that plague the philosophical basis of modern neuroscience but he needs to think more clearly about the source of the metaphysical errors that plague neuroscience, which is materialism.

See also: Did consciousness evolve? A Darwinist responds. Jerry Coyne argues that consciousness is a mere byproduct of useful traits that are naturally selected. But wait (Michael Egnor)

Further reading on the brain as a computer (or probably not)

We will never solve the brain. A science historian offers a look at some of the difficulties we face in understanding the brain. In a forthcoming book, science historian Matthew Cobb suggests that we may need to be content with different explanations for different brain parts. And that the image of the brain as a computer is definitely on the way out.

Why the brain is not at all like a computer. Seeing the brain as a computer is an easy misconception rather than an informative image, says neuroscientist Yuri Danilov.

Brains are not billions of little computers. Despite the hype. Also, life forms are not machines and neurons are not neural networks.

The brain is not a meat computer. Dramatic recoveries from brain injury highlight the difference. (Michael Egnor)

The brain exceeds the most powerful computers in efficiency.

and

Some people think and speak with only half a brain. A new study sheds light on how they do it.

Originally posted here:
The Mind Is the Opposite of a Computer - Walter Bradley Center for Natural and Artificial Intelligence

Eleusis Announces Published Preclinical Research Revealing Long Lasting Antidepressant-Like Effects of Psychedelics When Compared to Ketamine in…

LONDON & NEW YORK--(BUSINESS WIRE)--Eleusis, a clinical stage life science company established to develop the therapeutic potential of psychedelics, today announced the publication of its sponsored preclinical research in the American Chemical Societys journal Chemical Neuroscience, which suggests that psychedelics may have more persistent antidepressant therapeutic efficacy than ketamine. The study also indicates that the antidepressant effect of psychedelics are both biological and context-dependent, and the subjective existential experience or mystical experience often associated with psychedelics may be correlated with, but not cause, the persisting antidepressant effect.

The publication, titled Psychedelics, but not ketamine, produce persistent antidepressant-like effects in a rodent experimental system for the study of depression is the first direct preclinical comparison of the antidepressant efficacy of psychedelics and ketamine. The research reveals that both psilocybin and lysergic acid diethylamide (LSD) significantly reduce depressive-like behaviors five weeks after a single administration, while only the lowest dose of ketamine evaluated (5.0 mg/kg) was efficacious in decreasing depressive-like behaviors, and that the associated antidepressant-like effects of a single treatment with ketamine were transient compared to those observed in the psilocybin and LSD-treated rats and lasted less than two weeks.

The environment research animals were exposed to in the days immediately following treatment with psilocybin shaped the nature of the antidepressant-like and anti-anxiety outcomes, suggesting that contextual experiences following drug treatment were important factors in determining overall responses. The research suggests this may be due to enhanced learning of new coping behaviors as a result of psilocybin or LSD administration, an effect not observed in animals treated only with ketamine, or saline.

Our research is the first direct comparison of the degree and duration of antidepressant-like effects of psychedelics and ketamine in animals, and the first to demonstrate that what the animal experiences the first week after drug administration influences its long-term behavioral outcome. We believe these results further support the promising research and development of psychedelics as therapeutic medicines. said Meghan Hibicke Ph.D., the studys lead author and Postdoctoral Researcher at LSU Health Sciences Center, Pharmacology and Experimental Therapeutics.

Prior to our study, the scientific premise of whether or not a profound subjective existential experience is necessary for psilocybin to have antidepressant effects had not been evaluated either clinically, or preclinically, said Charles Nichols Ph.D., the director of the study and Professor of Pharmacology at Louisiana State University. Based on our findings, we believe that the robust antidepressant effects of psychedelics are intrinsically linked to a biological response, which may be correlated with, but not dependent on, the profound subjective experiences associated with psychedelics.

These intriguing findings suggest that continued research will yield new understandings of the basic mechanisms giving rise to the robust and enduring effects of psychedelics, said Shlomi Raz, Chairman and founder of Eleusis. "These study results, and other ongoing research directed by Eleusis, further confirm the vast therapeutic potential of psychedelics, and are serving to accelerate our companys ongoing efforts to transform psychedelics into medicines.

About Eleusis Ltd.

Eleusis is a privately-held, clinical stage life science company, established to unlock the transformative potential of psychoactive drugs, through the mitigation and management of psychoactivity. The company is developing an innovative platform of drug discovery and care delivery solutions to enable the transformation of groundbreaking university research into urgently needed therapeutic alternatives across a broad spectrum of inflammatory disease and mental health needs.

Follow Eleusis on LinkedIn and Twitter

Read more:
Eleusis Announces Published Preclinical Research Revealing Long Lasting Antidepressant-Like Effects of Psychedelics When Compared to Ketamine in...

Immersion Neuroscience Uncovers What Folks Really Love With a Little Help From PR Mavens at Bob Gold & Associates – Business Wire

LOS ANGELES--(BUSINESS WIRE)--Immersion Neuroscience, the worlds most advanced predictive software company unlocking neuroscience to measure what people love, has selected Bob Gold & Associates, a nationally recognized boutique public relations and marketing agency, as its public relations agency of record to help launch its new cloud-based audience prediction platform. The Immersion platform helps companies identify, quantify and predict what live or taped events, training, and entertainment motivate audiences to action so that companies can significantly improve their ability to connect with consumers and increase ROI.

"With more than two decades of research, weve developed an entirely new way to understand how the brain values content, and how to predict what content will drive actions with high accuracy," said Paul J. Zak, Ph.D., Founder of Immersion. We coined the term immersion to denote a measurable neurologic state, and today, Immersion offers an easy to use and powerful tool that allows any company to analyze content and predict how audiences will respond. And it doesn't take a neuroscientist to know that Bob Gold & Associates, with their unparalleled expertise and a proven track record, is the right company to help get our story told.

Immersions proprietary solution and software is the world's most accurate way to measure the brain's unconscious emotional responses to virtually any type of content whether its video, music, live events, training, educational resources and more. Developed by distinguished research scientists, Immersions simple to use and scalable predictive SaaS platform democratizes neuroscience so that anyone can measure what people love at scale.

Life doesnt happen inside a lab, Zak added. Until now, companies could only measure what people in the real world said they liked not how their brains were truly valuing an experience. Immersion is able to measure what folks truly, viscerally love, anywhere, anytime and in real time.

The Immersion platform infers when the brain values an experience in real-time with a small wearable sensor that can be used anywhere. Unlike traditional neuroscience technologies that use expensive, immobile and delicate lab equipment and require highly trained professionals to collect and analyze the data, Immersion takes multiple measures of brain activity and puts them into an easy to understand 0-10 measure collected every second. Immersions clients use the platform anywhere, anytime and at scale, empowering companies to predict future behavior and market outcomes with 90% or better accuracy.

"Immersion is a revolutionary company. With their unique cloud-based solution, measuring brain activity is no longer confined to a laboratory with expensive instruments," said Bob Gold, CEO of Bob Gold & Associates. "There are billions of dollars being spent in original programming, half of which never connects with audiences. Today for every network and streaming service, hits are everything. Immersion has proven, with peer-reviewed publications and blinded studies, its ability to identify hit shows, movies, songs and so much more.

Because its built in the cloud, and not in a lab, Immersions software is portable and effortlessly scalable, enabling clients to leverage the power of neuroscience on the fly, anywhere in the world. And while other companies can take months to compile results, Immersions software provides an immediate assessment, unlocking the power of neuroscience for anyone without the need for extensive training.

In one study, for example, two measures from the platform peak immersion, and frustration were enough to predict the top-rated unscripted TV shows with 84% accuracy.

Many leading global brands are already utilizing Immersion in countless ways. This includes shaping content and business decisions by predicting hit TV shows and movies, chart-topping songs, sales bumps, TV ratings, viral content, what has the highest impact at live events, and even HR and corporate training, all by accurately identifying what is truly valued by audience members brains.

For more about Bob Gold & Associates, visit http://www.bobgoldpr.com.

To learn more about Immersion, visit http://www.getimmersion.com.

View post:
Immersion Neuroscience Uncovers What Folks Really Love With a Little Help From PR Mavens at Bob Gold & Associates - Business Wire

Future of Education: Human Development and Psychology The Long View – Harvard Graduate School of Education

This event will be live-streamed on March 7 at 3:45 p.m.

Where has the field of human development been? Where is it now? Where is it going? Where should it go? Panelists will reflect on the ideas that have been central to their respective areas of the field including neuroscience, media and technology, and adolescent development and how ideas have evolved. Speakers will also share their concerns about the future of human development as well as their hopes for how the field might make greater contributions to both our understanding of child and adult development and our efforts to improve education.

Senior Lecturer Richard Weissbourd

Katie DavisAssociate Professor University of Washington Information School

Charles NelsonProfessor of Pediatrics and Neuroscience; Professor of Education, Harvard University

Nancy HillCharles Bigelow Pfessor of Education, HGSE

Marcelo Suarez-OrozcoWasserman Dean and Distinguished Professor of Education, UCLA Graduate School of Education and Information Studies

Kathleen McCartneyPresident, Smith College

William DamonProfessor of Education, Stanford University

The Future of Education is HGSEs Centennial discussion series, meant to explore less-visible ideas and solutions, share new knowledge, and foster constructive conversation about the most important issues in education. Throughout 2020, these convenings will dig deep into critical topics and big-picture ideas, with scholars, practitioners, and thought leaders from across and beyond the education sector.

Read this article:
Future of Education: Human Development and Psychology The Long View - Harvard Graduate School of Education

Helmets protect athletes’ skulls. Will the NFL use neuroscience to protect their brains? – Massive Science

As a spectator, its easy to forget the long term consequences of 300 pound humans crashing intoeach other at over 20 miles per hour. But this is the reality of American football. During play, the brain is one of the most susceptible parts of the body and thelong-termdanger may remain hidden until years after retirement.

New safety rules and improved helmets prevent injuries such as skull fractures. But no amount of training or equipment is yet known to prevent concussions, internal brain injuries caused when the brain shakes back and forth, or chronic traumatic encephalopathy (CTE), the neurodegenerative disease that results from accumulated hits to the head. The best thing we can do is stop playing these types of sports. The second best option is to mitigate the risks.

The NFL is plagued with controversy over the league's relationship with head injuries. Traditional helmets are designed to prevent skull fractures. However, concussions are not just blunt force trauma, but results of rotational forces exerted when the head snaps back and forth.

Symptoms of CTE don't appear until years or decades after chronic impacts

Wikimedia Commons

If the NFL wants to get serious about concussion prevention, as many believe they morally have a responsibility to do, independent neuroscience has to have a leading role in how helmets are designed.While the NFL denies bias in how they use science, it is impossible to deny that they have a large financial interest in the results, and this has led to questionable measures on head protection. From 1994 to 2009, the NFL actually employed their own research committee. But the committee was overhauled in 2009 after criticismfrom Congress for their continued denial of the link between football and brain disease.

And then there are equipment companies like Riddell, which was sued by thousands of former NFL players in 2013 for falsely claiming that players using their Revolution helmet were 31 percent less likely to get a concussion. Riddell based their marketing on a study of their new helmet by scientists at the University of Pittsburgh Medical Center. Even when the authors of the paper informed Riddell that their interpretation of their results was wrong (the actual reduction was closer to 2 percent), Riddell failed to alter the original claim.

Sciences approach for the modern American football helmet

If youve ever been a passenger in a car that suddenly slams on its breaks, you know a little of what it's like to be tackled. You probably fall forward, kept in your seat by your seat belt. The car stopped, but you were still rapidly accelerating. You experienced a linear force.Measurements on a college player showed the average acceleration of 10 hits he took during a single game. Each hit was roughly equivalent to what you would feel if you crashed a car into a wall going about 30 miles per hour.

Players' brains are very vulnerable in such a high-impact sport

Photo by Robina Weermeijer on Unsplash

Understanding of concussions and CTE has evolved significantly over the past few years and helmet designs are now just starting to catch up with the research. For example, scientists once thought that a concussion only bruised the outer grey matter surface of the brain.New research published over the past five years demonstrates that the brain doesnt bruise, but does experience rotational forces and damage extending to white matter, deep tissue in the brain, as the fibers in white matter pull and twist upon impact.

Designing a better helmet is about being creative about reducing the rapid deceleration of the brain upon impact. In 2013, the start up company VICIS set out to create a helmet based on this current medical knowledge, with neurosurgeons, concussion specialists, and former NFL team physicians as advisers. Their approach focused on rotational forces on the brain instead of just linear ones.

Thanks to the more than $85 million raised, $1.1 million from the NFL, they launched the ZERO1 helmet in 2016. This product has a reflex layer'' inside the shell composed of dozens of separate columns of padding, which bend, compress, and move in response to force in every direction, whether it's linear or rotational. The helmet also has a deformable'' outer shell that morphs its shape when hit, acting like a car bumper to absorb the blow. Since acceleration is speed divided by time, you can reduce acceleration by either decreasing speed or prolonging the time of the impact. The idea behind the car bumper properties of ZERO1 is that it increases thetime of impact.

In 2018, 120 professional and college teams wore the ZERO1. Performance testing suggests that this collaborative approach between scientists and sports was working. The ZERO1 football helmet was ranked #1 in ability to reduce force to the head in the NFLs and NFL Player Association helmet laboratory performance testing from 2017-2019, every year it has been available.

While this innovative helmet design washailed by neuroscientists, players, and sports leagues alike, VICIS did not survive competition with Schutt and Riddell, the two dominant companies in the helmet industry. In late 2019, VICIS announced it was out of money.

Other scientists are taking up the challenge to build a better helmet. David Camarillo is not just an Assistant Professorat Stanford University, he is also a former college football tight end. In 2013,his research labdeveloped computerized mouth guards to help accurately chart head acceleration data upon head impacts.

Former NFL player Junior Seau died at age 43. The NIH concluded that he suffered from CTE

Wikimedia Commons

While most helmets use solids to absorb energy, like foam or the columns in the VICIS ZERO1, the Camarillo lab'sapproach introduces liquid into thehelmetwith the idea that liquids can absorb more energy than solids. Camarillo compares the design to a hydraulic shock absorber." The team used computer simulations of an NFL impact test and compared the liquid approach with four other helmets with different energy absorption technologies. Results from his study suggest that the helmet reduces the average brain tissue strain upon impact by about 25 percent and could reduce concussions by at least 75 percent. However, as these results are still based entirely on computer simulations, the safety and logistics of building an actual helmet are still in research stages.

A concussion is not the same as CTE

While these new helmets are intended to prevent concussions, singular events caused by one hit, they may still be insufficient to protect against CTE. CTE is a neurodegenerative disease resulting from cumulative hits, whether they are concussive or not, that occur many times over many years. CTE is nearly impossible to study as symptoms almost never occur until many years or decades after repeated head trauma and positive diagnosis is only possible through an autopsy after death.

Ann McKee is a neuropathologist and expert in neurodegenerative diseases. She also directs Boston Universitys CTE Center. Her 2017 paper became famous when it suggested that 99 percent of former NFL players showed pathological evidence of CTE based on data collected from former players whose brains had been donated to Boston brain banks. The paper was scrutinized on the grounds that brains donated for CTE diagnosis may be biased towards CTE presence (i.e. family members saw the signs while the donor was alive). Her 2019 article enhances the correlation by being the first paper to include a non-football playing control group.

Experts are still trying to understand how head injuries, concussions, and other factors change the brain to cause CTE.Some scientists, such as the VICIS team and the Camarillo lab, believe that reducing the fierceness of the hardest hits that result in isolated concussions through more effective helmets will reduce the number and severity of CTE cases.

In the past decade, the NFL has spent over$200 million on concussion research, with multi-million dollar contributions in 2016 and 2018. However, at least some of that research has been overshadowed by what seems on the surface like a practice of funding labs associated with the NFL while withholding funds from labs that are critical of the organization. Players' lives are at stake and it is beyond time that the multi-billion dollar organizations that run this sport start putting players over profits. New helmet designs may be exciting parts of the solution, but only if the goal remains focused on sparing participants a lifetime of brain damage. In mid-November 2019, the NFL announced a $2 million grant competition to create a new top performing helmet. Let's hope that it will go to unbiased researchers with good intentions.

More:
Helmets protect athletes' skulls. Will the NFL use neuroscience to protect their brains? - Massive Science

What Neuroscience Can Tell Us About Nutrition – Thrive Global

Extreme obesity can knock eight years off your life, according to one Canadian study. But even being overweight has a clear impact on how we age. One study found that obese people had substantially less white matter in their brains than leaner people. While our brains naturally shrink with age, the brains of the obese people were found to have a comparable white matter volume to a lean person 10 years their senior. The impact on cognitive function is not known, but its unlikely to be good.

Obesity is the main cause of type 2 diabetes, which is most prevalent in older people. The number of Brits with type 2 diabetes has doubled in 20 years and it now accounts for almost 9 per cent of the annual NHS budget. A third of Americans over 65 now have type 2 diabetes. The consequences can be really nasty: blurred vision, sores which wont heal, even toe, foot and leg amputations.

Type 2 diabetes develops when our bodies consume so many carbohydrates that the pancreas ceases to release the right amounts of the hormone insulin into the blood, to regulate the glucose that gives us energy. Our systems are overwhelmed and they fail.

People who head into their sixties obese are storing up real trouble in Extra Time. Doctors are wary of interfering, because they feel that what we eat is a lifestyle choice. Personally, Im not so sure how much of a choice it is. Public health agencies have spent decades exhorting people to lose weight with almost no effect. I have become convinced that one reason we find it so hard to lose weight is that junk foodespecially sugaris addictive.

When I served on the board of the Care Quality Commission, the national regulator for hospitals, the scourge of obesity was every-where. Hospitals were having to reinforce beds for super-sized patients. Doctors were refusing knee replacements to people who were so overweight they feared the replacements would buckle under the strain. Some of those people became less active because their joints hurt and so gained even more weight. It was a terrible vicious cycle.

Around the same time I watched a talk by the American paediatric endocrinologist Professor Robert Lustig. He argues that sugar is the main cause of obesity, because sugar is as addictive as nicotine and switches on the same hormonal pathways which reward behaviour. Low blood sugar affects mood, concentration and the ability to inhibit impulse. Eating or drinking something sugary reverses the effect, but if the pattern is repeated for long enough, it results in insulin resistance, type 2 diabetes, heart disease and obesity. Professor Lustig believes that it is not possible for most people to quit through willpower because that has been eroded by the cycle of craving.

My mothers switch from nicotine to sugar made Lustigs narrative especially compelling for me: she simply replaced one addiction with another. And it chimed with my own experience. Battling exhaustion after my third child, and sitting opposite a fellow columnist who practically mainlined Coca-Cola, I fell into the habit of needing a Coke and chocolate bar before every deadline. Since I was filing copy almost everyday, as a Times leader writer, my consumption of sugar was considerable. And pretty soon the chocolate bar was no longer a single small, elegant Green & Blacks, but a string of Yorkie bars.

This kind of mindless eating has been brought to life, hilariously and poignantly, in experiments by Brian Wansink of Cornell University. In one, he gave stale popcorn to two groups of cinema-goers. One group got big buckets, the other got giant buckets so large that researchers assumed no one would finish them. When the movie ended, the people with giant buckets had scoured them clean theyd consumed 50 per cent more popcorn than the others. When told this, most were astonished.

For decades, we were warned off saturated fat. A profitable industry grew up selling low-fat processed foods. But these are a con. To make them tasty, manufacturers stuff them with carbohydrates and sugar. These create spikes in blood-sugar levels, which lead to cravings when blood sugar falls, along with the brains chemical messenger, dopamine. Dopamine gives pleasure, but also regulates our self-control. So Big Food offering low-fat cakes is the equivalent of Big Tobacco offering low-tar cigarettes: they make us feel better about ourselves, while keeping us hooked.

I hope that doesnt sound hysterical. In 2015, there was a mortifying moment when I was called a health fascist by one of the prime ministers other advisers. We had just come out of his office in Downing Street, where I had been arguing that we should tax sugary drinks. I was taken aback to hear myself described as fascist. But I believed we could no longer rely on exhortation to stem the obesity epidemicwe needed manufacturers to change their ingredients.

In 2016, the UK government announced that it would levy a tax on sugary drinks to tackle obesity. By the time the levy came into force two years later, most brands had already done what we had hoped they would: reformulate to avoid the tax, thus withdrawing substantial amounts of sugar from the supermarket shelves. While a few customers have complained about taste and Coca-Cola has refused to dilute its legendary Classic many are switching to low-sugar products. This suggests that relatively small signals can change markets.

Reformulating food is much more complicated for the obvious reason that processed foods contain far more ingredients than drinks (if you remove all the sugar from a cake, it will simply collapse and look like a souffl). But the UK government has already had some success in working with manufacturers to remove salt from processed foods. The same could be done for sugarwith the right combination of goodwill and political drive.

The assault on cigarettes was only partially about taxing and making them more expensive. It also involved health warnings on packets and restrictions on advertising. We need clear, unequivocal health warning on processed food and drink in a universal language, not complex labels in small print that few of us can make sense ofespecially when were rushing down a supermarket aisle, vulnerable to pester power. One doctor recently told me that the government should be focusing on parents and grandparents, not child obesity. Unless the parents and grandparents lose weight, she said, weve got no chance with the children.

Parents and grandparents may not trust government, or the media, to tell them what to do. But they do trust doctors.

Follow ushereand subscribeherefor all the latest news on how you can keep Thriving.

Stay up to date or catch-up on all our podcasts with Arianna Huffingtonhere.

Read the original post:
What Neuroscience Can Tell Us About Nutrition - Thrive Global

Immersion Neuroscience Uncovers What Folks Really Love With a Little Help From PR Mavens at Bob Gold & Associates – Yahoo Finance

Award Winning Agency Will Help Democratize Neuroscience for Companies Worldwide

Immersion Neuroscience, the worlds most advanced predictive software company unlocking neuroscience to measure what people love, has selected Bob Gold & Associates, a nationally recognized boutique public relations and marketing agency, as its public relations agency of record to help launch its new cloud-based audience prediction platform. The Immersion platform helps companies identify, quantify and predict what live or taped events, training, and entertainment motivate audiences to action so that companies can significantly improve their ability to connect with consumers and increase ROI.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200302005126/en/

"With more than two decades of research, weve developed an entirely new way to understand how the brain values content, and how to predict what content will drive actions with high accuracy," said Paul J. Zak, Ph.D., Founder of Immersion. "We coined the term immersion to denote a measurable neurologic state, and today, Immersion offers an easy to use and powerful tool that allows any company to analyze content and predict how audiences will respond. And it doesn't take a neuroscientist to know that Bob Gold & Associates, with their unparalleled expertise and a proven track record, is the right company to help get our story told."

Immersions proprietary solution and software is the world's most accurate way to measure the brain's unconscious emotional responses to virtually any type of content whether its video, music, live events, training, educational resources and more. Developed by distinguished research scientists, Immersions simple to use and scalable predictive SaaS platform democratizes neuroscience so that anyone can measure what people love at scale.

"Life doesnt happen inside a lab," Zak added. "Until now, companies could only measure what people in the real world said they liked not how their brains were truly valuing an experience. Immersion is able to measure what folks truly, viscerally love, anywhere, anytime and in real time."

The Immersion platform infers when the brain values an experience in real-time with a small wearable sensor that can be used anywhere. Unlike traditional neuroscience technologies that use expensive, immobile and delicate lab equipment and require highly trained professionals to collect and analyze the data, Immersion takes multiple measures of brain activity and puts them into an easy to understand 0-10 measure collected every second. Immersions clients use the platform anywhere, anytime and at scale, empowering companies to predict future behavior and market outcomes with 90% or better accuracy.

"Immersion is a revolutionary company. With their unique cloud-based solution, measuring brain activity is no longer confined to a laboratory with expensive instruments," said Bob Gold, CEO of Bob Gold & Associates. "There are billions of dollars being spent in original programming, half of which never connects with audiences. Today for every network and streaming service, hits are everything. Immersion has proven, with peer-reviewed publications and blinded studies, its ability to identify hit shows, movies, songs and so much more."

Because its built in the cloud, and not in a lab, Immersions software is portable and effortlessly scalable, enabling clients to leverage the power of neuroscience on the fly, anywhere in the world. And while other companies can take months to compile results, Immersions software provides an immediate assessment, unlocking the power of neuroscience for anyone without the need for extensive training.

In one study, for example, two measures from the platform peak immersion, and frustration were enough to predict the top-rated unscripted TV shows with 84% accuracy.

Many leading global brands are already utilizing Immersion in countless ways. This includes shaping content and business decisions by predicting hit TV shows and movies, chart-topping songs, sales bumps, TV ratings, viral content, what has the highest impact at live events, and even HR and corporate training, all by accurately identifying what is truly valued by audience members brains.

For more about Bob Gold & Associates, visit http://www.bobgoldpr.com.

To learn more about Immersion, visit http://www.getimmersion.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200302005126/en/

Contacts

Andrew LaszacsBob Gold & Associates 310-320-2010immersion@bobgoldpr.com

Originally posted here:
Immersion Neuroscience Uncovers What Folks Really Love With a Little Help From PR Mavens at Bob Gold & Associates - Yahoo Finance